KaydedilenlerDerginizi ekleyin

Dergiler / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 12

A bioinformatical approach to the pathogenesis of Fragile X premutation carriers

Elif PALA
Sayfa
3032–3036
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this study, it was aimed todetermine the differentially expressed genes of FMR1 premutation carriers and healthy controls by using bioinformatics techniques.Material and Methods: Gene expression profiles were downloaded from the Gene Expression Omnibus (GEO) database, which wereanalyzed using the Principal Component Analysis (PCA)-based unsupervised feature extraction (FE).Results: The set of 14 genes were identified that could successfully discriminate fragile X premutation carriers and healthy controls,and the majority of these genes were long non-coding RNAs (lncRNA).Conclusion: Although the results of our study should be supported by extended experimental researches, these genes have thepotential to be used as biomarkers and therapeutic targets.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The common cause of hereditary mental retardation is Fragile X Syndrome (FXS).
📊
Temel Bulgular & Veri:This disease occurs when the trinucleotiderepeat number (CGG)n in the promoter region of the Fragile X mental retardation 1 (FMR1) gene located in Xq27.3 is increased.Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disease caused by CGG repeat increase to 55-200 inthe FMR1 gene.
💡
Sonuç & Katkı:In this study, it was aimed todetermine the differentially expressed genes of FMR1 premutation carriers and healthy controls by using bioinformatics techniques.Material and Methods: Gene expression profiles were downloaded from the Gene Expression Omnibus (GEO) database, which wereanalyzed using the Principal Component Analysis (PCA)-based unsupervised feature extraction (FE).Results: The set of 14 genes were identified that could successfully discriminate fragile X premutation carriers and healthy controls,and the majority of these genes were long non-coding RNAs (lncRNA).Conclusion: Although the results of our study should be supported by extended experimental researches, these genes have thepotential to be used as biomarkers and therapeutic targets.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: The common cause of hereditary mental retardation is Fragile X Syndrome (FXS). This disease occurs when the trinucleotiderepeat number (CGG)n in the promoter region of the Fragile X mental retardation 1 (FMR1) gene located in Xq27.3 is increased.Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disease caused by CGG repeat increase to 55-200 inthe FMR1 gene. Although regulation disorders or mutations in FMR1 seem to be responsible for the pathogenesis of FXS and FXTAS,the broad phenotypic spectrum suggests that there should be some other potential genes involved. In this study, it was aimed todetermine the differentially expressed genes of FMR1 premutation carriers and healthy controls by using bioinformatics techniques.Material and Methods: Gene expression profiles were downloaded from the Gene Expression Omnibus (GEO) database, which wereanalyzed using the Principal Component Analysis (PCA)-based unsupervised feature extraction (FE).Results: The set of 14 genes were identified that could successfully discriminate fragile X premutation carriers and healthy controls,and the majority of these genes were long non-coding RNAs (lncRNA).Conclusion: Although the results of our study should be supported by extended experimental researches, these genes have thepotential to be used as biomarkers and therapeutic targets.

🔖

Bu Makaleye Atıf Yap

PALA, E. (2022). A bioinformatical approach to the pathogenesis of Fragile X premutation carriers. Annals of Medical Research, Cilt: 26 - Sayı: 12, 3032–3036. https://ajindex.com/articles/446807

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 2007;30:575-621
  2. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14
  3. Saldarriaga W, Tassone F, González-Teshima LY, et al. Fragile X syndrome. Colomb Med 2014;45:190-8
  4. Fu Y-H, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-58
  5. Peprah E. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet 2012;76:178-91
  6. Tassone F, Hagerman RJ, Garcia-Arocena D, et al. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ ataxia syndrome. J Med Genet 2004;41:43
  7. Hessl D, Tassone F, Loesch DZ, et al. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 2005;139:115-21
  8. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001;57:127- 30
  9. Sullivan A, Marcus M, Epstein M, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-12
  10. Coffey SM, Cook K, Tartaglia N, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 2008;146:1009-16
  11. Hagerman RJ, Leavitt B, Farzin F, et al. Fragile-X– associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004;74:1051-6
  12. Chiurazzi P, de Graaff E, Ng J, et al. No apparent involvement of the FMR1 gene in five patients with phenotypic manifestations of the fragile X syndrome. Am J Hum Genet 1994;51:309-14
  13. Reyniers E, Wolff G, Tariverdian G, et al. Severe mental retardation and macroorchidism without mutation in the FMR1 gene. Am J Hum Genet 1996;64:408-12
  14. Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile X–associated tremor/ataxia syndrome in a premutation carrier population. Jama 2004;291:460-9
  15. Borovecki F, Lovrecic L, Zhou J, et al. Genomewide expression profiling of human blood reveals biomarkers for Huntington’s disease. Proc Natl Acad Sci USA 2005;102:11023-8
  16. Haugen AC, Di Prospero NA, Parker JS, et al. K. Altered gene expression and DNA d